The Utility of Sirolimus Eluting Balloons in the Setting of Chronic Limb Threatening Ischaemia in Asian Patients from Singapore – 12 Months Results of the PRISTINE Registry
CardioVascular and Interventional Radiology · 2024
DOI: 10.1007/s00270-024-03756-3 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift CardioVascular and Interventional Radiology, 2024. Verfasst von T Y Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Vascular & Endovascular Clinic, Gleneagles Medical Centre, Singapore, 258499, Singapore. tjuntang@vascularclinic.sg. Hauptthemen laut MEDLINE: Registries, Sirolimus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
The aim of PRISTINE was to evaluate the 6 and 12 months safety and efficacy of the Selution Sustained Limus Release (SLR) ™ sirolimus-coated balloon for treatment of complex lower limb occlusive lesions (TASC II C & D) in patients with chronic limb threatening ischemia (CLTI) from Singapore.
Methods
PRISTINE was a prospective, non-randomized, single arm, observational, multi-investigator, single-center clinical study. Complication-free survival at 30 days was the safety clinical endpoint. Immediate technical success (ability to cross and dilate the lesion and achieve residual angiographic stenosis < 30%), 6-month primary vessel patency, limb salvage, clinically driven target lesion revascularization (TLR) and amputation free survival (AFS) were the efficacy endpoints of interest.
Results
Seventy five patients were included. There were 50 (68.0%) males; mean age, 69.0 ± 10.7 years. CLTI severity was based on the Rutherford Scale (R5 = 51; R6 = 17). Significant co-morbidities included diabetes mellitus ( n = 68; 91.0%) and end-stage renal failure ( n = 28; 37.0%). 112 atherosclerotic lesions were treated (TASC II D = 58 (52%); 76 (67%) de novo). There was 100% technical success. Mean lesion length treated was 22.4 ± 13.9 cm. Primary vessel patencies at 6 and 12 months were 64/86 (74%) and 43/74 (58%) and freedom from clinically driven TLR were 72/86 (84%) and 55/74 (74%) respectively. AFS was 61/73 (84.0%; five deaths and seven major lower extremity amputation) at 6-months. Mean Rutherford score improved from 5.1 ± 0.55 at baseline to 1.1 ± 2.05 ( p < 0.05) at one year and there was a wound healing rate of 38/48 (79%) at the same timepoint.
Conclusions
The Selution SLR ™ drug eluting balloon is safe and efficacious in treating highly complex infra-inguinal atherosclerotic lesions in an otherwise challenging frail population of CLTI patients with a high incidence of diabetes and end-stage renal failure. It is associated with highly satisfactory acute technical and clinical success, 12-month target lesion patency and AFS. Level of Evidence Level 2b, Individual Cohort Study. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Vascular & Endovascular Clinic, Gleneagles Medical Centre, Singapore, 258499, Singapore. tjuntang@vascularclinic.sg.
- Department of Vascular Surgery, Singapore General Hospital, Singapore, Singapore.
- Health Services Research Center, SingHealth, Singapore, Singapore.
- Department of Vascular Interventional Radiology, Singapore General Hospital, Singapore, Singapore.
Zitieren
APA
Tang, T. Y., Yap, C., Chan, S. L., Soon, S. X. Y., Sivanathan, C., Gogna, A., Patel, A. K., & Chong, T. T. (2024). The Utility of Sirolimus Eluting Balloons in the Setting of Chronic Limb Threatening Ischaemia in Asian Patients from Singapore – 12 Months Results of the PRISTINE Registry. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-024-03756-3
Vancouver
Tang TY, Yap C, Chan SL, Soon SXY, Sivanathan C, Gogna A, et al. The Utility of Sirolimus Eluting Balloons in the Setting of Chronic Limb Threatening Ischaemia in Asian Patients from Singapore – 12 Months Results of the PRISTINE Registry. CardioVascular and Interventional Radiology. 2024. doi:10.1007/s00270-024-03756-3
BibTeX
@article{Tang2024,
author = {Tang, T Y and Yap, C and Chan, S L and Soon, S X Y and Sivanathan, C and Gogna, A and Patel, A K and Chong, T T},
title = {The Utility of Sirolimus Eluting Balloons in the Setting of Chronic Limb Threatening Ischaemia in Asian Patients from Singapore – 12 Months Results of the PRISTINE Registry},
journal = {CardioVascular and Interventional Radiology},
year = {2024},
doi = {10.1007/s00270-024-03756-3}
}
EUVIMED